The international generic pharmaceuticals company, Actavis Group, has launched the oncology product Gemcitabine in EU markets, at patent expiry. This launch represents a significant milestone in Actavis’ developing hospital business. The pharmacuetical drug Gemcitabine is the first major oncology product to be made available by Actavis on the date of patent ... Read More...
- The Engine Listed Among the Ten Best Digital Marketing Agencies in Europe January 7, 2021
- Icelandic tarot deck wins International Tarot Foundation prizes December 7, 2020
- Iceland Aviation Academy becomes market leader in the Nordic region November 30, 2020
- Valka introduces a revolutionary salmon cutter November 26, 2020
- Comply by TBI – The next generation of VAT Compliance software November 25, 2020
Submit Your Press Release at eNewsWire
eNewsWire is an online press release service offering both free and paid distribution. eNewWire distributes business, organisational and personal news and press releases using the Internet. Submit your press release here.